Target Volume Definition in Non-Small Cell Lung Cancer
暂无分享,去创建一个
[1] Liesbeth Boersma,et al. Feasibility of pathology-correlated lung imaging for accurate target definition of lung tumors. , 2007, International journal of radiation oncology, biology, physics.
[2] P. Remeijer,et al. Set-up verification using portal imaging; review of current clinical practice. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[3] André Wambersie,et al. The International Commission on Radiation Units and Measurements , 2001, Journal of the ICRU.
[4] Nandita Mitra,et al. Elective nodal irradiation (ENI) vs. involved field radiotherapy (IFRT) for locally advanced non-small cell lung cancer (NSCLC): A comparative analysis of toxicities and clinical outcomes. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[5] Jinming Yu,et al. Determining optimal clinical target volume margins on the basis of microscopic extracapsular extension of metastatic nodes in patients with non-small-cell lung cancer. , 2007, International journal of radiation oncology, biology, physics.
[6] K. Bujko,et al. Impact of [18F]fluorodeoxyglucose PET-CT staging on treatment planning in radiotherapy incorporating elective nodal irradiation for non-small-cell lung cancer: a prospective study. , 2011, International journal of radiation oncology, biology, physics.
[7] Di Yan,et al. Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation. , 2003, International journal of radiation oncology, biology, physics.
[8] Bernard Dubray,et al. Conformal radiotherapy for lung cancer: different delineation of the gross tumor volume (GTV) by radiologists and radiation oncologists. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[9] T. Uematsu,et al. Treatment of roentgenographically occult endobronchial carcinoma with external beam radiotherapy and intraluminal low-dose-rate brachytherapy: second report. , 2000, International journal of radiation oncology, biology, physics.
[10] C. Williams,et al. Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable): a systematic review , 2001, Thorax.
[11] Suresh Senan,et al. European Organisation for Research and Treatment of Cancer recommendations for planning and delivery of high-dose, high-precision radiotherapy for lung cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] Michael K Gould,et al. Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition). , 2007, Chest.
[13] M. V. van Herk,et al. The probability of correct target dosage: dose-population histograms for deriving treatment margins in radiotherapy. , 2000, International journal of radiation oncology, biology, physics.
[14] T. Rice,et al. Utility of positron emission tomography compared with mediastinoscopy for delineating involved lymph nodes in stage III lung cancer: insights for radiotherapy planning from a surgical cohort. , 2008, International journal of radiation oncology, biology, physics.
[15] Hak Choy,et al. A phase II comparative study of gross tumor volume definition with or without PET/CT fusion in dosimetric planning for non-small-cell lung cancer (NSCLC): primary analysis of Radiation Therapy Oncology Group (RTOG) 0515. , 2009, International journal of radiation oncology, biology, physics.
[16] Jan-Jakob Sonke,et al. Adaptive radiotherapy for lung cancer. , 2010, Seminars in radiation oncology.
[17] S. Kudoh,et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] T. Naruke,et al. Lymph node mapping and curability at various levels of metastasis in resected lung cancer. , 1978, The Journal of thoracic and cardiovascular surgery.
[19] S. Davies,et al. Big brother : Britain's web of surveillance and the new technological order , 1996 .
[20] Hisao Asamura,et al. The IASLC Lung Cancer Staging Project: A Proposal for a New International Lymph Node Map in the Forthcoming Seventh Edition of the TNM Classification for Lung Cancer , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[21] C. Mountain,et al. Regional lymph node classification for lung cancer staging. , 1997, Chest.
[22] Ursula Nestle,et al. Practical integration of [18F]-FDG-PET and PET-CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): the technical basis, ICRU-target volumes, problems, perspectives. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[23] S. Sak,et al. Changing patterns of lung cancer; (3/4 in.) 1.9 cm; still a safe length for bronchial resection margin? , 2000, Lung cancer.
[24] I. Park,et al. Long-term survival following pneumonectomy for non-small cell lung cancer: clinical implications for follow-up care. , 2007, Chest.
[25] D. Yan,et al. Clinicopathologic analysis of microscopic extension in lung adenocarcinoma: defining clinical target volume for radiotherapy. , 2007, International journal of radiation oncology, biology, physics.
[26] J C Rosenwald,et al. Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning. , 2000, International journal of radiation oncology, biology, physics.
[27] N. Willich,et al. Effect of preoperative chemoradiation in addition to preoperative chemotherapy: a randomised trial in stage III non-small-cell lung cancer. , 2008, The Lancet. Oncology.
[28] Giuseppe Lucio Cascini,et al. Current status of PET/CT for tumour volume definition in radiotherapy treatment planning for non-small cell lung cancer (NSCLC). , 2007, Lung cancer.
[29] Tomio Inoue,et al. Use of PET and PET/CT for radiation therapy planning: IAEA expert report 2006-2007. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[30] D. de Ruysscher,et al. Variations in target volume definition for postoperative radiotherapy in stage III non-small-cell lung cancer: analysis of an international contouring study. , 2010, International journal of radiation oncology, biology, physics.
[31] J. Battista,et al. Radiation treatment of lung cancer--patterns of practice in Canada. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[32] Designing targets for elective nodal irradiation in lung cancer radiotherapy: a planning study. , 2009, International journal of radiation oncology, biology, physics.
[33] Suresh Senan,et al. 4D imaging for target definition in stereotactic radiotherapy for lung cancer , 2006, Acta oncologica.
[34] Jinming Yu,et al. A Randomized Study of Involved-Field Irradiation Versus Elective Nodal Irradiation in Combination With Concurrent Chemotherapy for Inoperable Stage III Nonsmall Cell Lung Cancer , 2007, American journal of clinical oncology.
[35] Marcel van Herk,et al. Observer variation in target volume delineation of lung cancer related to radiation oncologist-computer interaction: a 'Big Brother' evaluation. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[36] Jan-Jakob Sonke,et al. Kilo-voltage cone-beam computed tomography setup measurements for lung cancer patients; first clinical results and comparison with electronic portal-imaging device. , 2007, International journal of radiation oncology, biology, physics.
[37] Otto S Hoekstra,et al. The size of mediastinal lymph nodes and its relation with metastatic involvement: a meta-analysis. , 2006, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[38] B. Jeremic,et al. Report from the International Atomic Energy Agency (IAEA) consultants' meeting on elective nodal irradiation in lung cancer: non-small-Cell lung cancer (NSCLC). , 2008, International journal of radiation oncology, biology, physics.
[39] Otto S Hoekstra,et al. Detection and Staging of Preinvasive Lesions and Occult Lung Cancer in the Central Airways with 18F-Fluorodeoxyglucose Positron Emission Tomography: A Pilot Study , 2005, Clinical Cancer Research.
[40] R. Fisher,et al. Measurement of lung tumor volumes using three-dimensional computer planning software. , 2002, International journal of radiation oncology, biology, physics.
[41] K. Bujko,et al. Dose-per-Fraction Escalation of Accelerated Hypofractionated Three-Dimensional Conformal Radiotherapy in Locally Advanced Non-small Cell Lung Cancer , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[42] K. Bujko,et al. Cardiopulmonary morbidity and quality of life in non-small cell lung cancer patients treated with or without postoperative radiotherapy. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[43] Carsten Brink,et al. Deviations in delineated GTV caused by artefacts in 4DCT. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[44] S. Sak,et al. Proximal bronchial extension with special reference to tumor localization in non-small cell lung cancer. , 2001, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[45] W. Oyen,et al. FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0 , 2009, European Journal of Nuclear Medicine and Molecular Imaging.
[46] S. Senan,et al. What margins are necessary for incorporating mediastinal nodal mobility into involved-field radiotherapy for lung cancer? , 2002, International journal of radiation oncology, biology, physics.
[47] S. Lehnert,et al. Defining radiotherapy target volumes using 18F-fluoro-deoxy-glucose positron emission tomography/computed tomography: still a Pandora's box? , 2010, International journal of radiation oncology, biology, physics.
[48] S. Sak,et al. Prognostic implications of microscopic proximal bronchial extension in non-small cell lung cancer. , 2002, The Annals of thoracic surgery.
[49] P. Voet,et al. Can errors in reconstructing pre-chemotherapy target volumes contribute to the inferiority of sequential chemoradiation in stage III non-small cell lung cancer (NSCLC)? , 2002, Lung cancer.
[50] Liesbeth Boersma,et al. Microscopic disease extension in three dimensions for non-small-cell lung cancer: development of a prediction model using pathology-validated positron emission tomography and computed tomography features. , 2012, International journal of radiation oncology, biology, physics.
[51] Lawrence B Marks,et al. Elective nodal irradiation for locally advanced non-small-cell lung cancer: it's called cancer for a reason. , 2009, International journal of radiation oncology, biology, physics.
[52] Suresh Senan,et al. Tumor location cannot predict the mobility of lung tumors: a 3D analysis of data generated from multiple CT scans. , 2003, International journal of radiation oncology, biology, physics.
[53] J. Daurès,et al. Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Français de Pneumo-Cancérologie NPC 95-01 Study. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[54] Eike Rietzel,et al. Design of 4D treatment planning target volumes. , 2006, International journal of radiation oncology, biology, physics.
[55] R. Arriagada,et al. Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients. , 1991, Journal of the National Cancer Institute.
[56] W. Curran,et al. Final Results of Phase III Trial in Regionally Advanced Unresectable Non-Small Cell Lung Cancer : Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group , 2000 .
[57] Di Yan,et al. Defining a radiotherapy target with positron emission tomography. , 2002, International journal of radiation oncology, biology, physics.
[58] J. Herndon,et al. Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial. , 1996, Journal of the National Cancer Institute.
[59] K. Bujko,et al. Risk of isolated nodal failure for non-small cell lung cancer (NSCLC) treated with the elective nodal irradiation (ENI) using 3D-conformal radiotherapy (3D-CRT) techniques – A retrospective analysis , 2008, Acta oncologica.
[60] R. Rami-Porta,et al. Complete resection in lung cancer surgery: proposed definition. , 2005, Lung cancer.
[61] Marcel van Herk,et al. Reduction of observer variation using matched CT-PET for lung cancer delineation: a three-dimensional analysis. , 2006, International Journal of Radiation Oncology, Biology, Physics.
[62] G. Giaccone,et al. Randomised trial of sequential versus concurrent chemo-radiotherapy in patients with inoperable non-small cell lung cancer (EORTC 08972-22973). , 2007, European journal of cancer.
[63] Lucyna Kepka,et al. Delineation variation of lymph node stations for treatment planning in lung cancer radiotherapy. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[64] Ladislav Pecen,et al. Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study. , 2004, Lung cancer.
[65] Arjan Bel,et al. Definition of gross tumor volume in lung cancer: inter-observer variability. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[66] Eike Rietzel,et al. Maximum-intensity volumes for fast contouring of lung tumors including respiratory motion in 4DCT planning. , 2008, International journal of radiation oncology, biology, physics.
[67] Randall K Ten Haken,et al. CT-based definition of thoracic lymph node stations: an atlas from the University of Michigan. , 2005, International journal of radiation oncology, biology, physics.
[68] K. Rosenzweig,et al. Probability of mediastinal involvement in non-small-cell lung cancer: a statistical definition of the clinical target volume for 3-dimensional conformal radiotherapy? , 2006, International journal of radiation oncology, biology, physics.
[69] D. Galetta,et al. Adjuvant radiotherapy in non-small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[70] P. Lambin,et al. HI-CHART: a phase I/II study on the feasibility of high-dose continuous hyperfractionated accelerated radiotherapy in patients with inoperable non-small-cell lung cancer. , 2008, International journal of radiation oncology, biology, physics.
[71] Icru. Prescribing, recording, and reporting photon beam therapy , 1993 .
[72] Jan-Jakob Sonke,et al. Mid-ventilation CT scan construction from four-dimensional respiration-correlated CT scans for radiotherapy planning of lung cancer patients. , 2006, International journal of radiation oncology, biology, physics.
[73] K. Ulm,et al. Simultaneous chemoradiotherapy compared with radiotherapy alone after induction chemotherapy in inoperable stage IIIA or IIIB non-small-cell lung cancer: study CTRT99/97 by the Bronchial Carcinoma Therapy Group. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[74] S. Burdett,et al. Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials , 1998, The Lancet.
[75] J. Herndon,et al. Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage III Non-small-cell lung cancer: Cancer and Leukemia Group B. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[76] M. Tsao,et al. PET CT thresholds for radiotherapy target definition in non-small-cell lung cancer: how close are we to the pathologic findings? , 2010, International journal of radiation oncology, biology, physics.